Background: Given the number of publications appearing annually regarding drug-induced
liver injury (DILI), there remains a need to concisely summarize each year's new crop of …

Aliment Pharmacol Ther 2011; 34: 11–20 Summary Background Drug‐induced liver injury
(DILI) is a significant cause of morbidity and mortality accounting for at least 13% of acute …

Drug-induced liver injury (DILI), herbal-induced liver injury, and herbal and dietary
supplement (HDS)-induced liver injury are an important aspect of drug safety. Knowledge …

Interest in drug-induced liver injury (DILI) has dramatically increased over the past decade,
and it has become a hot topic for clinicians, academics, pharmaceutical companies and …

Introduction: The year 2013 continued to highlight numerous aspects of drug-induced liver
injury (DILI), with new information communicated via> 1500 publications. New reports of DILI …

Retrospective studies of administrative databases have led to highly variable estimates of
the incidence and natural history of drug‐induced liver injury (DILI) and the agents …

Drug-induced liver injury (DILI) remains a challenge in clinical practice and is still a
diagnosis of exclusion. Although it has a low incidence amongst the general population, DILI …

Drug-induced liver injury (DILI) is an infrequent cause of liver disease in the general
population and accounts for-< 1% of hospitalized patients presenting with jaundice. 1, 2 …

Drug-induced liver injury (DILI), also known as hepatotoxicity, refers to liver injury caused by
drugs or other chemical agents, and represents a special type of adverse drug reaction. It …

OBJECTIVE: Drug-induced liver injury (DILI) is more often a challenge even for expert
clinicians. Presently, there are limited data about the epidemiology, because the real …